Kenya’s health ministry announced that a Kenyan citizen, who had been living in the Democratic Republic of Congo (DR Congo), died after testing positive for the Bundibugyo species of Ebola. The case marks the first recorded Ebola death in Kenya, prompting a rapid public‑health response.
What happened
The patient fell ill in DR Congo, was treated in several local hospitals, and then travelled by road to Kampala, Uganda, before boarding a flight to Nairobi on a Saturday. After a routine screening at Nairobi’s main airport, he was taken to a hospital and later transferred to an isolation facility built during the COVID‑19 pandemic. There, he developed fever, chills, intense fatigue, painful swallowing, muscle pain and sub‑cutaneous bleeding. Samples collected by doctors tested positive for the Bundibugyo Ebola virus.
He died at 23:30 (20:30 GMT) on Monday. His burial is planned for the following day in accordance with public‑health safety protocols.
Immediate response
Health Minister Aden Duale urged the public not to panic, emphasizing that "all systems are in place to mitigate the spread of the disease". The ministry has taken the following steps:
- Contact tracing: 28 contacts—including family members and healthcare workers—have been identified.
- Further tracing: Authorities are pursuing 23 passengers and four crew members who were on the same flight.
- Infection control: Health workers have been instructed to maintain heightened infection‑prevention measures for all patients.
Regional context
The outbreak in DR Congo is the second‑most lethal Ebola outbreak on record, with the World Health Organization (WHO) reporting 4,082 deaths out of 8,463 confirmed cases. The disease is spreading in the conflict‑ridden eastern provinces, where rebel activity and limited health infrastructure hamper surveillance.
Earlier in the year, the virus was also reported in Uganda, where two deaths occurred before the WHO declared the country Ebola‑free in August. Since then, all known cases have been confined to DR Congo until this Kenyan case.
What’s next
Kenyan authorities continue to monitor the situation closely. Ongoing actions include:
- Expanding contact tracing to all individuals who may have been exposed.
- Maintaining isolation facilities and ensuring they are equipped for high‑risk infections.
- Coordinating with the WHO and regional partners to monitor the spread of the Bundibugyo strain.
While there are currently no approved vaccines or treatments for the Bundibugyo species, four vaccine candidates are in development, with human trials for one having started in July. The health ministry’s message remains clear: vigilance and strict infection‑control practices are essential to prevent further transmission.